Pericardial Involvement in ST-Segment Elevation Myocardial Infarction as Detected by Cardiac MRI

Eias Massalha1, Yafim Brodov1,2, Daniel Oren1,3

  • 1The Olga and Lev Leviev Heart Center, Sheba Medical Center, Affiliated With the Sackler School of Medicine, Tel Aviv University, Ramat Gan, Israel.

Abstract

Insights

Pericardial involvement, detected by late pericardial enhancement (LPE) in 77.5% of ST-segment elevation myocardial infarction (STEMI) patients, surprisingly correlates with a lower rate of major adverse cardiac events (MACE). This finding challenges previous assumptions about pericarditis post-myocardial infarction.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Post-myocardial infarction pericarditis is often underestimated due to diagnostic limitations.
  • Current diagnostic methods rely on clinical and echocardiographic parameters, potentially missing subclinical pericardial involvement.

Purpose of the Study:

  • To determine the incidence, extent, and prognostic significance of pericardial involvement in ST-segment elevation myocardial infarction (STEMI) using cardiac MRI (CMR).
  • To investigate the relationship between pericardial enhancement and myocardial injury, and its impact on long-term patient outcomes.

Main Methods:

  • 187 STEMI patients underwent CMR, including LGE and SSFP sequences, on day 5 post-admission.
  • Late pericardial enhancement (LPE) was identified on LGE sequences and correlated with myocardial injury (LGE, MVO) and clinical outcomes (MACE).

Main Results:

  • Late pericardial enhancement (LPE) was observed in 77.5% of STEMI patients.
  • LPE showed a strong association with the extent and severity of myocardial injury (LGE, MVO).
  • Contrary to expectations, LPE presence was linked to a significantly lower rate of major adverse cardiac events (MACE) over 3 years.

Conclusions:

  • Cardiac MRI effectively documents pericardial involvement (LPE) in a high percentage of STEMI patients.
  • Pericardial involvement in STEMI, while associated with myocardial damage, appears to have a protective prognostic implication.
  • These findings necessitate a re-evaluation of the role and prognosis of pericarditis in the context of acute myocardial infarction.

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
146
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
40
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
46
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
100
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
36